Drug Discovery Solutions

  1. Drug Substance Synthesis And Manufacturing 3/3/2022

    We take an agile and flexible approach with our customers programs, offering bespoke drug substance synthesis and manufacturing, helping to accelerate molecules from candidate selection to clinical proof-of-concept and onwards towards commercial scale.

  2. Oncology Solutions: Accelerate Your Cancer Therapeutics Development 6/20/2022

    Aragen offers solutions from lead candidate selection to their development, preclinical trials, clinical trials, and GMP manufacturing under one roof.

  3. Accelerating Oligonucleotides Discovery And Development Programs 6/13/2025

    Leverage advanced oligonucleotide synthesis capabilities to accelerate the development of ASOs, siRNA, miRNA, and other nucleic acid-based therapeutics.

  4. CHEF1™ Expression Technology 2/17/2022

    The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.

  5. Robust Cell Line Development With Leap-In Transposase® 5/15/2023

    Improve your cell line development and achieve high productivity, rapid timelines, low risk development, and robust genetic stability with an innovative platform.

  6. Analytical Labs Particle Analysis

    Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.

  7. Aragen's Preclinical Oncology Capabilities 3/27/2025

    We provide specialized in vivo pharmacology services, offering customized solutions to support the development of immune-oncology therapies from discovery to commercialization.

  8. In Vitro Pharmacology 6/13/2025

    Our team collaborates closely with clients to deliver tailored solutions spanning cell and protein sciences, assay development and validation, and high-throughput screening.

  9. Discover A Platform For Antibodies With Increased ADCC Activity 5/15/2023

    Explore a platform for antibodies with increased ADCC activity that's compatible with various host cell lines, works across multiple vector configurations, and reduces core fucose within any cell line.

  10. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.